Costs and Outcomes Comparison of Diabetes Technology Usage Among People With Type 1 or 2 Diabetes Using Rapid-Acting Insulin.

ABSTRACT:

Background

Does initiation of a continuous glucose monitor (CGM) or insulin pump lower health care utilization and/or costs?

Methods

Distinct cohorts of people with type 1 diabetes (T1D) or type 2 diabetes (T2D) using a blood glucose monitor (BGM), CGM, pump, or CGM with pump were identified from a large claims database. Patients ≥40 years old with 12 months of continuous enrollment before and after the device start date qualified for the study. Outcomes included one-year medical utilization and costs (minus device) for events such as hospitalizations and office visits. Generalized linear models were fitted, controlling for numerous baseline covariates. The Holm method corrected for the multiplicity of hypotheses tested.

Results

Of the 8235 total patients, the BGM con

SUBMITTER: Vallarino CR 

PROVIDER: S-EPMC10012356 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature